BIOSIM INNOVATIONS
LIVE

Serial Number

90028467

Owner

Sky Blue Ventures LLC

Attorney

Wesley Schwie

First Use Date

Jun 29, 2020

Filing Date

Jun 30, 2020

Add to watchlist:

No watchlists yet
View on USPTO

BIOSIM INNOVATIONS Trademark

Serial Number: 90028467 • Registration: 6599314

BIOSIM INNOVATIONS is a trademark filed by Sky Blue Ventures LLC on June 30, 2020. The trademark is classified under Class 40 (Treatment & Processing), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Sky Blue Ventures LLC (9 trademarks)

23581 Juniper Court
Rogers, MN 55374

Entity Type: 16

BIOSIM INNOVATIONS LLC

7625 BOONE AVE N.
BROOKLYN PARK, MN 55428

Entity Type: 16

Trademark Details

Filing Date

June 30, 2020

Registration Date

December 21, 2021

First Use Anywhere

June 29, 2020

First Use in Commerce

June 29, 2020

Goods & Services

Medical training; training services in the fields of medicine, medical technology, medical procedures, interventional procedures, surgical procedures, interventional cardiology, interventional radiology, and vascular intervention for physicians; training physicians in the use and operation of medical imaging apparatus; training physicians in the use and operation of ultrasound, fluoroscope, and endoscope apparatuses; training physicians in the use and operation of medical imaging apparatuses utilizing testing models with human and animal tissue, cell cultures, tissue cultures, and organ cultures; biosimulator model development in the nature of developing medical training programs for others utilizing biosimulation technology

Manufacture of medical devices to the order and specification of others; prototype fabrication of medical devices for others

Engineering services, namely, medical device prototype development and medical device development for others; biosimulator model development in the nature of product development for others utilizing biosimulation technology; laboratory services for purposes of testing of new products for others utilizing testing models with human and animal tissue, cell cultures, tissue cultures, and organ cultures; experimental design and consulting regarding patient health risk analysis for product development of medical devices

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 11, 2025 ASGN
REGISTERED-SUPPLEMENTAL REGISTER
Dec 21, 2021 R.SR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 17, 2021 PREV
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Nov 15, 2021 CNTA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 9, 2021 CRFA
ASSIGNED TO LIE
Nov 8, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 3, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 4, 2021 GNRN
NON-FINAL ACTION E-MAILED
May 4, 2021 GNRT
NON-FINAL ACTION WRITTEN
May 4, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 13, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 12, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 12, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 13, 2020 GNRN
NON-FINAL ACTION E-MAILED
Oct 13, 2020 GNRT
NON-FINAL ACTION WRITTEN
Oct 13, 2020 CNRT
ASSIGNED TO EXAMINER
Oct 5, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 28, 2020 NWOS
NEW APPLICATION ENTERED
Jul 3, 2020 NWAP